“REAL WORLD” EXPERIENCE OF TOFACITINIB AND BARICITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: EFFECTIVENESS AND SAFETY EVALUATION (submitted in 2019) |
“REAL LIFE” EFFECTIVENESS AND SAFETY ASSESSMENT OF FOSCARNET |
“Leadership” the word on hospital pharmacists' lips at Vienna Congress |
“Description and Follow-up of the Use of Emtricitabin/ Tenofovir for HIV Pre-Exposure Prophylaxis |
“Clinical research helpdesk”: an active support for investigators in a large university hospital |
“CAPSULE PHARMA”, AN INNOVATIVE DIGITAL TRAINING TOOL TO LEARN ABOUT IMPORTANT STERILE MEDICAL DEVICE (SMD) CONCEPTS |
‘START SMART’: IMPROVING THE QUALITY OF EMPIRIC ANTIMICROBIAL PRESCRIBING IN A TERTIARY CHILDREN’S HOSPITAL SETTING |
‘REAL WORLD’ EXPERIENCE OFELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN THE TREATMENT OF CYSTIC FIBROSIS: EFFECTIVENESS AND SAFETY EVALUATION |
‘LOCK, STOCK AND FLOW’–IMPROVING THE SUPPLY OF CONTROLLED DRUGS IN A TERTIARY REFERRAL TEACHING HOSPITAL |
Δ-9-TETRAHYDROCANNABINOL(SATIVEX) FOR THE TREATMENT OF MULTIPLE SCLEROSIS SPASTICITY: EVALUATION OF EFFECTIVENESS AND SAFETY |